Trials that use: Risk ratio / relative risk
New to this method? Read the tutorial →
6,204 results
- MeCISIndependent statistical analysis of MethaCholine Bronchoprovocation Study (MeCIS): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00705341).
- MEDALISTIndependent statistical analysis of A Study of Luspatercept (ACE-536) to Treat Anemia Due to Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- MEDEXIndependent statistical analysis of A Multi-level Life-span Characterization of Adult-depression and Effects of Medication and Exercise: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- MEDI8897 Ph2bComplete statistical analysis of the randomized phase 2 MEDI8897 Ph2b trial evaluating MEDI8897 for prevention of medically attended RSV lower respiratory tract infection in healthy preterm infants.
- MedstarBC2Independent statistical analysis of MedStar Diabetes Pathway Chart Reviews: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03442595).
- Medtronic MiniMed Implantable Insulin Pump: Complete Statistical AnalysisIndependent statistical analysis of Medtronic MiniMed Implantable Insulin Pump: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00298740).
- Medtronic Resolute Onyx 2.0 mm Clinical Study: Complete Statistical AnalysisIndependent statistical analysis of Medtronic Resolute Onyx 2.0 mm Clinical Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02412501).
- MEK InhibitorIndependent statistical analysis of MEK Inhibitor PD-0325901 Trial in Adolescents and Adults With NF1: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02096471).
- MEK Inhibitor AZD6244 in Treating Patients With Stage III or Stage IV Melanoma: Complete Statistical AnalysisIndependent statistical analysis of MEK Inhibitor AZD6244 in Treating Patients With Stage III or Stage IV Melanoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- MEK Inhibitor MSC1936369B Plus FOLFIRI in Second Line K-Ras Mutated Metastatic Colorectal Cancer (mCRC): Complete Statistical AnalysisIndependent statistical analysis of MEK Inhibitor MSC1936369B Plus FOLFIRI in Second Line K-Ras Mutated Metastatic Colorectal Cancer (mCRC): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Mel47Independent statistical analysis of Temsirolimus and Bevacizumab in Treating Patients With Stage III or Stage IV Malignant Melanoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Mel55Independent statistical analysis of Study to Assess Safety and Immune Response of Stage IIB-IV Resected Melanoma After Treatment With MAGE-A3 ASCI: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Melatonin for Circadian Sleep Disorders in the Blind: Complete Statistical AnalysisIndependent statistical analysis of Melatonin for Circadian Sleep Disorders in the Blind: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00911053).
- Melatonin Postoperative Sleep Study in Breast Cancer Patients: Complete Statistical AnalysisIndependent statistical analysis of Melatonin Postoperative Sleep Study in Breast Cancer Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00506064).
- Melphalan and Panobinostat (LBH589) for the Treatment of Patients With Recurrent Multiple Myeloma: Complete Statistical AnalysisIndependent statistical analysis of Melphalan and Panobinostat (LBH589) for the Treatment of Patients With Recurrent Multiple Myeloma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Men Together Making a Difference: Reducing HIV/STD Risk Behavior Among South African Men: Complete Statistical AnalysisIndependent statistical analysis of Men Together Making a Difference: Reducing HIV/STD Risk Behavior Among South African Men: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- MENDEL-2Independent statistical analysis of Monoclonal Antibody Against PCSK9 to Reduce Elevated LDL-C in Subjects Currently Not Receiving Drug Therapy for Easing Lipid Levels-2: primary endpoint results, effect estimate with confidence interval, sample-size…
- Menopur® Versus Follistim® in Polycystic Ovarian Syndrome (PCOS): Complete Statistical AnalysisIndependent statistical analysis of Menopur® Versus Follistim® in Polycystic Ovarian Syndrome (PCOS): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00805935).
- MERCURIndependent statistical analysis of A Study of Subcutaneous Mircera in Participants With Chronic Kidney Disease Not Treated With ESA or on Dialysis: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- Merits of Performing a Modified Template Retroperitoneal Lymph Node Dissection: Complete Statistical AnalysisIndependent statistical analysis of Merits of Performing a Modified Template Retroperitoneal Lymph Node Dissection: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00751140).
- Mesalamine 4 g Sachet for the Induction of Remission in Active, Mild to Moderate Ulcerative Colitis (UC): Complete Statistical AnalysisIndependent statistical analysis of Mesalamine 4 g Sachet for the Induction of Remission in Active, Mild to Moderate Ulcerative Colitis (UC): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Mesothelin-Targeted Immunotoxin LMB-100 in Combination With SEL-110 in Subjects With Malignant Pleural or Peritoneal Mesothelioma: Complete Statistical AnalysisIndependent statistical analysis of Mesothelin-Targeted Immunotoxin LMB-100 in Combination With SEL-110 in Subjects With Malignant Pleural or Peritoneal Mesothelioma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Metabolic Phenotyping During Stress Hyperglycemia in Cardiac Surgery Patients: Complete Statistical AnalysisIndependent statistical analysis of Metabolic Phenotyping During Stress Hyperglycemia in Cardiac Surgery Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03743025).
- Metabolic Syndrome and Fall Risk: Complete Statistical AnalysisIndependent statistical analysis of Metabolic Syndrome and Fall Risk: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02633891).
- Metazym for the Treatment of Patients With Late Infantile Metachromatic Leukodystrophy (MLD): Complete Statistical AnalysisIndependent statistical analysis of Metazym for the Treatment of Patients With Late Infantile Metachromatic Leukodystrophy (MLD): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Metformin as an Adjunctive Therapy to Catheter Ablation in Atrial Fibrillation: Complete Statistical AnalysisIndependent statistical analysis of Metformin as an Adjunctive Therapy to Catheter Ablation in Atrial Fibrillation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Metformin for the Prevention of Oral Cancer in Patients With Oral Leukoplakia or Erythroplakia: Complete Statistical AnalysisIndependent statistical analysis of Metformin for the Prevention of Oral Cancer in Patients With Oral Leukoplakia or Erythroplakia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Metformin Hydrochloride in Treating Patients With Prostate Cancer Undergoing Surgery: Complete Statistical AnalysisIndependent statistical analysis of Metformin Hydrochloride in Treating Patients With Prostate Cancer Undergoing Surgery: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01433913).
- Metformin in Kidney Disease: Complete Statistical AnalysisIndependent statistical analysis of Metformin in Kidney Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02252081).
- Metformin in Non Small Cell Lung Cancer (NSCLC): Complete Statistical AnalysisIndependent statistical analysis of Metformin in Non Small Cell Lung Cancer (NSCLC): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02285855).
- Metformin Pharmacology in Human Cancers: A Proof of Principle Study: Complete Statistical AnalysisIndependent statistical analysis of Metformin Pharmacology in Human Cancers: A Proof of Principle Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03477162).
- Metformin Versus Insulin in Pregnant Women With Type 2 Diabetes: Complete Statistical AnalysisIndependent statistical analysis of Metformin Versus Insulin in Pregnant Women With Type 2 Diabetes: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00678080).
- Methadone, Morphine, or Oxycodone in Treating Pain in Patients With Cancer: Complete Statistical AnalysisIndependent statistical analysis of Methadone, Morphine, or Oxycodone in Treating Pain in Patients With Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Method Comparison Study of the Spartan FRX CYP2C19 Genotyping System Against Bi-directional Sequencing: Complete Statistical AnalysisIndependent statistical analysis of Method Comparison Study of the Spartan FRX CYP2C19 Genotyping System Against Bi-directional Sequencing: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Methohexital v Propofol as General Anesthetic in Patients on ACEIs or ARBs: Complete Statistical AnalysisIndependent statistical analysis of Methohexital v Propofol as General Anesthetic in Patients on ACEIs or ARBs: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Methotrexate (Rheumatrex) High Dose Special Investigation (Regulatory Post Marketing Commitment Plan): Complete Statistical AnalysisIndependent statistical analysis of Methotrexate (Rheumatrex) High Dose Special Investigation (Regulatory Post Marketing Commitment Plan): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Methotrexate Compared With Dactinomycin in Treating Patients With Gestational Trophoblastic Neoplasia: Complete Statistical AnalysisIndependent statistical analysis of Methotrexate Compared With Dactinomycin in Treating Patients With Gestational Trophoblastic Neoplasia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Methotrexate With or Without Cyclophosphamide in Treating Patients With Lymphocytic Leukemia: Complete Statistical AnalysisIndependent statistical analysis of Methotrexate With or Without Cyclophosphamide in Treating Patients With Lymphocytic Leukemia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Methotrexate, Vincristine, Pegylated L-Asparaginase and Dexamethasone (MOAD) in Acute Lymphoblastic Leukemia (ALL) Salvage: Complete Statistical AnalysisIndependent statistical analysis of Methotrexate, Vincristine, Pegylated L-Asparaginase and Dexamethasone (MOAD) in Acute Lymphoblastic Leukemia (ALL) Salvage: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- METRASIndependent statistical analysis of Metabolites of Tramadol in the Postoperative Surgical Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04004481).
- Metvix PDT in Participant With “High Risk” Basal Cell Carcinoma: Complete Statistical AnalysisIndependent statistical analysis of Metvix PDT in Participant With "High Risk" Basal Cell Carcinoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00473343).
- MG-1Independent statistical analysis of Open-Label Study for Shoulder Dislocation Using MG-1: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01528319).
- MGC018 With or Without MGA012 in Advanced Solid Tumors: Complete Statistical AnalysisIndependent statistical analysis of MGC018 With or Without MGA012 in Advanced Solid Tumors: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03729596).
- MgPOEMIndependent statistical analysis of Magnesium for Peroral Endoscopic Myotomy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04638881).
- MGTA-456 in Patients With Inherited Metabolic Disorders Undergoing Hematopoietic Stem Cell Transplantation (HSCT): Complete Statistical AnalysisIndependent statistical analysis of MGTA-456 in Patients With Inherited Metabolic Disorders Undergoing Hematopoietic Stem Cell Transplantation (HSCT): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- MH MOVE!Independent statistical analysis of Improving Obesity Self-Care Among Mentally Ill Veterans: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02642536).
- MIAMINKIndependent statistical analysis of Safety Study of Liver Natural Killer Cell Therapy for Hepatoma Liver Transplantation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Microbiota Restoration Therapy for Recurrent Clostridium Difficile Infection: Complete Statistical AnalysisIndependent statistical analysis of Microbiota Restoration Therapy for Recurrent Clostridium Difficile Infection: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02589847).
- Microscopic Fluorescence-guided Vestibular Schwannoma Resection Using Fluorescein Sodium and YELLOW 560: Complete Statistical AnalysisIndependent statistical analysis of Microscopic Fluorescence-guided Vestibular Schwannoma Resection Using Fluorescein Sodium and YELLOW 560: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Microtubule-Targeted Agent BAL101553 and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma: Complete Statistical AnalysisIndependent statistical analysis of Microtubule-Targeted Agent BAL101553 and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…